Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pure Health Holding PJSCADX:PUREHEALTH -1.53%51 5-Year Yield-on-Cost % is 2.07 as of Sep. 15, 2026, which is 70% above its 10-year median of 1.22. GuruFocus rates ADX:PUREHEALTH with a GF Score™ of 51/100 and a GF Value™ of د.إ3.27 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 281 Healthcare Providers & Services companies, Pure Health Holding PJSC ranks worse than 61.57% on this metric.
The historical rank and industry rank for Pure Health Holding PJSC's 5-Year Yield-on-Cost % or its related term are showing as below:
ADX:PUREHEALTH'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1 Med: 1.22 Max: 2.44
Current: 2.07
During the past 5 years, Pure Health Holding PJSC's highest Yield on Cost was 2.44. The lowest was 1.00. And the median was 1.22.
ADX:PUREHEALTH's 5-Year Yield-on-Cost % is ranked worse than 61.57% of 281
companies
in the Healthcare Providers & Services industry
Industry Median: 2.96
vs ADX:PUREHEALTH: 2.07
Pure Health Holding PJSC (ADX:PUREHEALTH) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Pure Health Holding PJSC 5-Year Yield-on-Cost % Related Terms
ADX:PUREHEALTH vs HCA, THC, EHC: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Pure Health Holding PJSC's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pure Health Holding PJSC 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pure Health Holding PJSC's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Pure Health Holding PJSC's 5-Year Yield-on-Cost % falls into.
Pure Health Holding PJSC 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Pure Health Holding PJSC (ADX:PUREHEALTH) has a 5-Year Yield-on-Cost % of 2.07 as of Sep. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Pure Health Holding PJSC and its competitors. This is 70% above median its historical median of 1.22. Over the past decade, Pure Health Holding PJSC's 5-Year Yield-on-Cost % has ranged from 1.00 to 2.44. According to the industry distribution chart, Pure Health Holding PJSC ranks #173 out of 281 companies in the Healthcare Providers & Services industry, placing it in the top 61.6%.
Is Pure Health Holding PJSC's 5-Year Yield-on-Cost % too high?
Pure Health Holding PJSC's current 5-Year Yield-on-Cost % of 2.07 is 70% above median its 10-year median of 1.22. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 2.44. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.96. Pure Health Holding PJSC's value of 2.07 is 30.1% below this industry median. Based on the distribution chart, Pure Health Holding PJSC ranks #173 out of 281 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pure Health Holding PJSC has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pure Health Holding PJSC's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pure Health Holding PJSC ranks #173 out of 281 companies for 5-Year Yield-on-Cost %. This places Pure Health Holding PJSC in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.96. Pure Health Holding PJSC's value of 2.07 is 30.1% below this benchmark. Historically, Pure Health Holding PJSC's own 5-Year Yield-on-Cost % has ranged from 1.00 to 2.44 over the past decade. While the company's 10-year median is 1.22 vs. the industry median of 2.96, Pure Health Holding PJSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.96, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pure Health Holding PJSC's current 5-Year Yield-on-Cost % of 2.07 is 30.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Pure Health Holding PJSC and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pure Health Holding PJSC's current 5-Year Yield-on-Cost % is 2.07, which is 70% above median its own 10-year median of 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pure Health Holding PJSC stock overvalued right now?
Based on GuruFocus' analysis, Pure Health Holding PJSC (ADX:PUREHEALTH) is currently considered Modestly Undervalued. The stock's GF Value™ is د.إ3.27, compared to a current price of د.إ2.57 — trading 21.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 2.07, which is 70% above median its 10-year median of 1.22 and 30.1% below the Healthcare Providers & Services industry median of 2.96. Pure Health Holding PJSC's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Pure Health Holding PJSC (ADX:PUREHEALTH), the current 5-Year Yield-on-Cost % is 2.07 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pure Health Holding PJSC (ADX:PUREHEALTH) Overvalued in 2026?
Based on GuruFocus' analysis, Pure Health Holding PJSC stock appears to be undervalued.
The current stock price of د.إ2.57 is trading 21.4% below its estimated GF Value™ of د.إ3.27.
GuruFocus considers Pure Health Holding PJSC to be Modestly Undervalued.
Key valuation signals for ADX:PUREHEALTH:
5-Year Yield-on-Cost %: 2.07 (70% above median its 10-year median of 1.22)
GF Value™: د.إ3.27 vs. price of د.إ2.57 (21.4% below fair value)
Industry Position: 30.1% below the Healthcare Providers & Services median (#173 of 281)
No single metric tells the full story. See the ADX:PUREHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pure Health Holding PJSC is an integrated healthcare company in the United Arab Emirates with a cross-category ecosystem covering hospitals, clinics, diagnostics, insurance, pharmacies, research, health tech, and procurement, along with an international footprint in the United States and the United Kingdom. The company's reportable segments are Hospital and other healthcare related services, Health Insurance services, Diagnostic services, and Technology services and others. Key revenue is derived from the Hospital and other healthcare related services segment through which it provides general healthcare operations, including hospitalization, clinical, isolation/quarantine, vaccinations, and other services.
51GF Score
Get the complete analysis for ADX:PUREHEALTH
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADX:PUREHEALTH has been successfully added to your 
